Search

JCTCV:21(4), Objectives: Nowadays, prospective crossmatch is routinely performed for matching donor and recipient in kidney transplantation. Transplantation is decided only in case of a negative result. The practice leads us to think that a hyperimmunized lung transplantation candidate should also get a negative prospective crossmatch result before transplantation. We implemented a strategy for transplanting hyperimmunized patients using ”logistic” ex-vivo lung perfusion (EVLP) in order to safely extend preservation time while waiting for the prospective result of the crossmatch. Methods: We used EVLP as described by the Toronto Lung Transplantation team for 3 hyperimmunized patients at Foch Hospital. Results: Patients were 29, 47, and 49 years old, respectively. Two patients were awaiting lung transplantation for cystic fibrosis and one patient for emphysema. Mean EVLP length was 3 hours and 40 minutes with a total preservation time of 14 hours. Two patients had bilateral lung transplantation and one patient bilateral lobar transplantation. One patient was extubated in the operating room, while two others were extubated 5 and 7 days after transplantation, respectively. The mean ICU and hospital lengths of stay were 12 days and 25 days, respectively. During follow-up, no argument for antibody-mediated rejection or chronic allograft dysfunction was detected for the 3 patients. C4d was systematically negative. All patients are alive and well 3 years after transplantation. Conclusion: These 3 cases highlight “logistic” EVLP as suitable and safe for allowing lung transplantation in hyperimmunized patients.